22 related articles for article (PubMed ID: 38452695)
21. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma.
Jiapaer S; Furuta T; Tanaka S; Kitabayashi T; Nakada M
Neurol Med Chir (Tokyo); 2018 Oct; 58(10):405-421. PubMed ID: 30249919
[TBL] [Abstract][Full Text] [Related]
22. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.
Shahcheraghi SH; Tchokonte-Nana V; Lotfi M; Lotfi M; Ghorbani A; Sadeghnia HR
Curr Pharm Des; 2020; 26(15):1729-1741. PubMed ID: 32003685
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
